Signal
Nature published AlphaFold 3, a model for predicting the joint structure of biomolecular complexes across proteins, nucleic acids, small molecules, ions, and modified residues.
AlphaFold 3 extends structure prediction beyond proteins toward biomolecular complexes involving proteins, nucleic acids, small molecules, ions, and modified residues, moving parts of biology into a general computational modelling layer. Drug discovery and biological engineering increasingly depend on shared modelling infrastructure before experimental validation, changing where early-stage research time and capital are spent. У зв’язці з AI-агенти та Модульна автономність цей сигнал уже читається як частина системного маршруту.
Nature published AlphaFold 3, a model for predicting the joint structure of biomolecular complexes across proteins, nucleic acids, small molecules, ions, and modified residues.
Frontier medicine is moving upstream into computational biology: discovery pipelines start with modelled molecular interactions before lab validation and clinical translation.
The strategic asset shifts from individual molecules toward modelling platforms, validation datasets, experimental feedback loops, and teams that can connect AI prediction with wet-lab execution.